Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

Peer Review reports

Original Submission
7 Jul 2015	Submitted	Original manuscript
4 Aug 2015	Reviewed	Reviewer Report - Kenji Hashimoto
9 Aug 2015	Reviewed	Reviewer Report - Xiaojun Huang
11 Aug 2015	Reviewed	Reviewer Report - Victor Lasebikan
7 Sep 2015	Author responded	Author comments - Elisabeth Giraud-Baro
Resubmission - Version 2
7 Sep 2015	Submitted	Manuscript version 2
9 Oct 2015	Author responded	Author comments - Elisabeth Giraud-Baro
Resubmission - Version 3
9 Oct 2015	Submitted	Manuscript version 3
15 Nov 2015	Author responded	Author comments - Elisabeth Giraud-Baro
Resubmission - Version 4
15 Nov 2015	Submitted	Manuscript version 4
4 Dec 2015	Author responded	Author comments - Elisabeth Giraud-Baro
Resubmission - Version 5
4 Dec 2015	Submitted	Manuscript version 5
Publishing
8 Jan 2016	Editorially accepted
15 Jan 2016	Article published	10.1186/s12888-016-0712-1

Back to article page